ArticleCancer immunology, immunotherapy : CII2025

Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer.

Juheon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.